Free breast cancer screening guidelines Topical Map Generator
Use this free breast cancer screening guidelines topical map generator to plan topic clusters, pillar pages, article ideas, content briefs, AI prompts, and publishing order for SEO.
Built for SEOs, agencies, bloggers, and content teams that need a practical content plan for Google rankings, AI Overview eligibility, and LLM citation.
1. Screening Modalities & Guidelines
Explains available screening tests, comparative strengths/limitations, and authoritative guideline recommendations so readers know which test, when to start, and how often to screen. This group establishes clinical credibility and helps users navigate conflicting guidance.
Complete Guide to Breast Cancer Screening: Mammograms, MRI, Ultrasound and When to Start
A definitive, evidence-based guide to all breast cancer screening options and major guideline recommendations. Readers learn types of screening tests (digital mammography, tomosynthesis, ultrasound, MRI), how screening reduces mortality, trade-offs (false positives/overdiagnosis), and clear age- and risk-based screening schedules aligned with USPSTF, ACS, and specialty societies.
When should I start getting mammograms? Age and risk-based guidance
Clear, patient-focused explanation of when to start mammography depending on age and personal/family risk, comparing major guideline positions and offering a decision checklist for shared decision-making with clinicians.
Digital mammography vs 3D tomosynthesis (DBT): Benefits, limitations, and when to use each
Explains technological differences, sensitivity/specificity data, impact on recall rates, and practical recommendations for patients and clinics deciding between standard 2D and tomosynthesis screening.
Breast MRI for screening: who benefits and what to expect
Describes indications for screening MRI (e.g., BRCA carriers, very high lifetime risk), performance compared with mammography, preparation, contraindications, and how MRI fits into a high-risk surveillance plan.
The role of clinical breast exams and professional screening
Covers what a clinical breast exam (CBE) includes, evidence for and against routine CBE in population screening, and when a clinician-performed exam adds value.
Comparing major screening recommendations: USPSTF, ACS, NCCN, ACOG
Side-by-side comparison of major organizations' recommendations, the evidence base behind differences, and how to apply them to individual risk contexts.
Cost and access: how much does a mammogram cost and is it covered?
Practical guidance on typical costs, insurance coverage (private and public programs), low-cost screening resources, and what to ask your provider or insurer.
2. Breast Self-Exam & Symptom Recognition
Teaches effective breast self-awareness and self-exam techniques, clarifies symptoms that warrant medical evaluation, and debunks myths — empowering readers to notice changes early and seek appropriate care.
Breast Self-Exam and Symptom Guide: How to Check, What to Look For, and When to See a Doctor
A practical, step-by-step manual for breast self-exams and recognizing concerning signs. It distinguishes normal cyclic changes from suspicious findings, explains when to contact a clinician, and provides resources for teaching adolescents and partners.
How to do a breast self-exam: step-by-step with images and tips
Clear stepwise instructions for visual inspection and palpation, including positions, pressure technique, and a checklist to log findings and frequency.
What do breast lumps feel like? Distinguishing benign from suspicious findings
Describes common benign lumps (cysts, fibroadenomas) vs features more concerning for cancer, with guidance on urgency and next steps.
Breast changes during menstrual cycle, pregnancy and menopause: what’s normal
Explains cyclical tenderness, engorgement in pregnancy and lactation, and menopausal changes so readers can avoid unnecessary alarm while recognizing red flags.
When to see a doctor: red flags and urgent symptoms
Lists urgent warning signs (skin dimpling, nipple retraction, bloody discharge, rapidly growing mass) and recommended timelines for evaluation.
Teaching breast self-awareness to teens and young adults
Age-appropriate guidance for parents and educators on promoting body awareness and destigmatizing breast health in adolescents.
3. Diagnostic Follow-up & Biopsy
Covers the diagnostic pathway after an abnormal screen: what tests come next, how biopsies are done, interpreting pathology, and how multidisciplinary teams guide care — crucial for reducing anxiety and facilitating informed decisions.
What Happens After an Abnormal Breast Screening: Diagnostic Tests, Biopsy Types, and Next Steps
An authoritative walkthrough of diagnostic evaluation following abnormal imaging or symptoms. It explains BI-RADS categories, additional imaging options, biopsy techniques and pathology terminology, expected timelines, and how to coordinate second opinions and multidisciplinary care.
BI-RADS categories explained: what your report really means
Plain-language explanation of BI-RADS 0–6, recommended actions for each, and typical follow-up timelines so patients understand radiology reports.
Types of breast biopsy: fine needle, core needle, and surgical — what to expect
Compares biopsy techniques, procedural steps, pain management, risks, sample processing, and how results influence treatment decisions.
Interpreting pathology: DCIS, invasive carcinoma, benign findings and margin status
Breaks down common pathology terms, prognostic factors (grade, receptor status), and what each result typically means for next steps.
How long will diagnosis and staging take? Typical timelines and what can delay results
Expected timelines from abnormal screening to diagnostic imaging, biopsy, pathology report, and staging — plus common causes of delay and how to expedite care.
Preparing for a biopsy: pain, recovery, complications and aftercare
Practical pre- and post-procedure guidance on pain control, wound care, activity restrictions, infection signs and follow-up appointments.
4. Risk Assessment, Genetics & Personalized Screening
Provides in-depth coverage of risk factors, genetic testing, and how personalized risk alters screening and prevention strategies — essential for patients with family history or known mutations.
Assessing Breast Cancer Risk: Genetics, Family History, and Personalized Screening Plans
A clinician-grade guide to evaluating breast cancer risk using family history, validated risk models, and genetic testing. It explains BRCA and other actionable genes, when to refer for genetic counseling, and tailored screening and prevention options for high-risk individuals.
BRCA1/BRCA2 and other hereditary breast cancer genes: testing, implications, and management
Explains who should be tested, what positive/negative results mean for cancer risk, implications for relatives, and medical management options for carriers.
Risk calculators explained: Gail, Tyrer-Cuzick, and how clinicians estimate lifetime risk
Compares major risk models, their inputs and limitations, and how scores translate into screening and prevention recommendations.
Risk-reducing options: chemoprevention, prophylactic surgery, and lifestyle change
Evidence-based overview of tamoxifen, raloxifene, risk-reducing mastectomy/oophorectomy, pros/cons and patient selection criteria plus lifestyle measures that reduce risk.
When to refer to a genetic counselor and what to expect from counseling
Practical triggers for referral, the counseling process, consent and privacy considerations, and resources for finding counselors.
5. Dense Breasts & Supplemental Screening
Focuses on the clinical and practical issues around breast density: increased cancer risk, decreased mammogram sensitivity, notification laws, and evidence for supplemental screening — crucial for individualized screening decisions.
Dense Breasts: What Density Means, How It Affects Screening, and Supplemental Options
Explains breast density measurement, why dense tissue makes mammograms less sensitive and modestly raises cancer risk, and summarizes supplemental screening options (ultrasound, MRI, tomosynthesis) with evidence and practical guidance for patients and clinicians.
What does 'dense breasts' mean and how is density measured?
Defines BI-RADS density categories, how density is reported, and why density matters for imaging and risk.
Supplemental screening for dense breasts: ultrasound, MRI, and tomosynthesis compared
Compares effectiveness, false positive rates, logistical considerations, and evidence for outcomes of each supplemental modality for women with dense breasts.
Laws and notifications: what to do if you receive a dense breast notice
Explains typical contents of dense-breast notices, recommended next steps, and how to discuss options with your provider.
How to manage screening if you have dense breasts: a patient checklist
Practical, stepwise checklist (ask about prior imaging, discuss risk, consider supplemental tests, insurance questions) to guide patient-clinician conversations.
6. Follow-up Care, Survivorship & Navigating the System
Addresses what comes after screening or treatment — surveillance schedules, managing side effects, psychosocial support, and how to coordinate care across specialists — supporting long-term outcomes and quality of life.
Follow-up Care After Breast Screening or Treatment: Surveillance, Emotional Support, and Coordinating Care
A patient-centric guide to post-screening follow-up and survivorship, covering recommended surveillance after treatment, monitoring for recurrence, management of common sequelae (lymphedema, menopausal symptoms), psychosocial support, and how to build and use a survivorship care plan.
Surveillance schedule after breast cancer treatment: imaging and clinical follow-up
Evidence-based follow-up schedules for imaging and clinical visits after treatment, tailored by stage and treatment type, with red flags requiring earlier evaluation.
Coping with fear of recurrence and emotional recovery after screening or diagnosis
Practical strategies, therapy options, support networks and techniques to manage anxiety about recurrence that commonly follows abnormal screens or cancer treatment.
Lymphedema prevention and management after breast surgery or radiation
Covers risk factors, early signs, conservative treatments (compression, therapy), when to see a specialist, and prevention strategies for at-risk patients.
How to build a survivorship care plan and coordinate your care team
Templates and practical tips to create a survivorship care plan covering treatment summary, surveillance schedule, medication list, and contact points for providers.
Resources, financial assistance, and support groups for patients and caregivers
Curated list of national and local support organizations, financial aid programs, and practical services for transportation, childcare, and mental health support.
Content strategy and topical authority plan for Breast Health: Screening, Self-Exam, and Follow-up
Building topical authority on breast screening, self-exam and follow-up captures high-intent, recurring queries in a YMYL niche that drives referrals to clinics and paid services. Dominance means owning long-tail, guideline and navigational queries—resulting in steady organic traffic, high user trust, clinical backlinks and monetizable lead-generation opportunities.
The recommended SEO content strategy for Breast Health: Screening, Self-Exam, and Follow-up is the hub-and-spoke topical map model: one comprehensive pillar page on Breast Health: Screening, Self-Exam, and Follow-up, supported by 29 cluster articles each targeting a specific sub-topic. This gives Google the complete hub-and-spoke coverage it needs to rank your site as a topical authority on Breast Health: Screening, Self-Exam, and Follow-up.
Seasonal pattern: Search interest peaks strongly in October (Breast Cancer Awareness Month) with secondary bumps in January (health resolutions) and May (mother's day/health campaigns); baseline interest is otherwise year-round.
35
Articles in plan
6
Content groups
17
High-priority articles
~6 months
Est. time to authority
Search intent coverage across Breast Health: Screening, Self-Exam, and Follow-up
This topical map covers the full intent mix needed to build authority, not just one article type.
Content gaps most sites miss in Breast Health: Screening, Self-Exam, and Follow-up
These content gaps create differentiation and stronger topical depth.
- Practical, visual step-by-step self-exam modules (short video + annotated images) tied to when to seek care—most sites give text-only advice.
- Clear, user-friendly decision trees for supplemental screening in dense breasts that combine density, family history and age into actionable recommendations.
- Region-specific navigation guides: how to get timely diagnostic follow-up in different health systems, cost/insurance checklists and sample scripts for scheduling calls.
- Structured post-abnormal-result pathways (exact timelines, what to expect at biopsy, pathology report explainer templates and next-step checklists) that reduce no-shows and anxiety.
- Patient-facing summaries of guideline disagreements (e.g., age to start and interval differences) presented as plain-language pros/cons to support shared decision-making.
- Multilingual, culturally tailored educational materials addressing disparities in screening uptake and trust barriers among under-served populations.
- Interactive risk calculators that integrate family history, breast density and prior benign pathology with tailored screening and referral suggestions.
- Survivorship surveillance schedules with actionable content on lymphedema prevention, ongoing imaging cadence, and mental-health resources—many sites lack practical follow-up checklists.
Entities and concepts to cover in Breast Health: Screening, Self-Exam, and Follow-up
Common questions about Breast Health: Screening, Self-Exam, and Follow-up
At what age should I start getting screening mammograms?
Most guidelines recommend starting shared decision-making about screening at age 40 and routine screening by age 50; women aged 40–49 should discuss personal risk factors with a clinician to decide on earlier screening frequency. If you have high-risk factors (BRCA mutation, strong family history, prior chest radiation), screening often begins earlier (frequently age 25–30) with MRI plus mammography.
How often should I get a mammogram?
For average-risk women aged 50–74, biennial (every 2 years) mammography is commonly recommended; some clinicians and women choose annual screening starting at 40 based on risk and preferences. High-risk patients may require annual mammogram plus annual MRI staggered every 6 months for detection sensitivity.
What is the difference between mammogram, breast MRI and ultrasound and when is each used?
Mammography is the primary screening tool for average-risk women; ultrasound is used as a targeted problem-solving tool or supplemental screening in dense breasts; MRI is the most sensitive screening modality used for high-risk women (e.g., genetic mutations, prior chest radiation). Choice depends on risk level, breast density and prior imaging findings—MRI catches more cancers but has higher false-positive rates.
How do I perform a breast self-exam correctly and how often?
A practical self-check can be done monthly using a three-step approach: visual inspection in front of a mirror for symmetry or skin changes, systematic palpation lying down covering the entire breast and armpit area (use pads of fingers, varying pressure), and repeating upright or in the shower; do it monthly after menses in premenopausal women or pick a consistent day each month for postmenopausal women. Self-exams are not a substitute for screening but help with awareness—report new lumps, persistent changes, or nipple abnormalities promptly.
What does 'dense breasts' mean and how does it affect screening?
Breast density describes the proportion of fibroglandular tissue to fat on mammography; dense breasts (BI-RADS C or D) occur in roughly 40–50% of women and make mammograms less sensitive because dense tissue can mask cancers. Women with dense breasts may be offered supplemental screening (tomosynthesis, ultrasound or MRI) based on risk and local protocols.
I had an abnormal mammogram—what are the typical next steps and timeline?
After an abnormal screening mammogram you’ll often get diagnostic views and targeted ultrasound the same day or within 1–2 weeks; if imaging remains suspicious a biopsy (core needle or vacuum-assisted) is usually arranged and pathology results typically return within 3–10 business days. Keep proactive communication with the imaging center and your clinician about timelines and next steps—many programs offer nurse navigators to expedite follow-up.
Should I get genetic testing for BRCA or other inherited breast cancer genes?
Genetic testing is recommended when personal or family history meets established criteria—examples include multiple relatives with breast/ovarian cancer, early-onset breast cancer (<50), triple-negative disease, or known familial mutations. Testing decisions should be done with genetic counseling because results change screening frequency, preventive options (e.g., risk-reducing surgery), and family member implications.
Can mammograms cause breast cancer or harm fertility?
Modern screening mammograms use very low-dose radiation and have not been shown to cause breast cancer at the exposure levels used for screening; they do not affect fertility. The main harms to weigh are false positives, anxiety, and occasional unnecessary biopsies—not radiation-induced cancer at standard screening doses.
What follow-up is recommended after a benign biopsy or benign imaging result?
After a benign core biopsy, follow-up typically includes imaging at a short interval (often 6 months) and then returning to regular screening if stability is confirmed; specific intervals depend on pathology (e.g., high-risk lesions like atypia need more intensive surveillance or surgical consultation). Ensure reports clearly state recommended imaging follow-up and get a written plan from your clinician.
How should screening change during pregnancy or while breastfeeding?
Pregnancy and lactation complicate imaging: diagnostic ultrasound is preferred first for symptomatic evaluation, and mammography can be performed if clinically indicated with abdominal shielding; routine screening mammography is generally postponed until after breastfeeding unless there’s a suspicious finding. Any persistent lump during pregnancy or postpartum must be evaluated promptly—do not delay.
Publishing order
Start with the pillar page, then publish the 17 high-priority articles first to establish coverage around breast cancer screening guidelines faster.
Estimated time to authority: ~6 months
Who this topical map is for
Health publishers, women’s health clinics, patient advocacy nonprofits and clinician content teams creating an authoritative hub for screening guidance, symptom recognition, and clear follow-up pathways.
Goal: Own the local-to-national informational funnel for breast screening and follow-up: rank for guideline and how-to queries, convert visitors into clinic referrals or genetic-testing leads, and be the trusted resource clinicians link to for patient education.